Work

Access in all areas? A round-up of developments in market access and health technology assessment: part 10

Year: 2025

Type: article

Abstract: In this update, we examine the US' Food and Drug Administration (FDA) Commissioner's National Priority Voucher pilot program; The Netherlands' Zorginstituut Nederland (ZIN) implementation framework for the EU HTA Regulation; and Italy's Agenzia Italiana del Farmaco (AIFA) refined criteria for assessing therapeutic innovativeness.

Source: Journal of Comparative Effectiveness Research

DOI: 10.57264/cer-2025-0138

Authors: Sreeram V Ramagopalan, Annie Jullien Pannelay

Institution: King's College London

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Zorginstituut Nederland, Agenzia Italiana del Farmaco, Ministero della Salute